Investor Relations

Home > Investor Relations > IR Library > Statements of Cash Flows (consolidated)

Statements of Cash Flows (consolidated)

(million yen) 
  FY2015
(2015/4/1-2016/3/31)
FY2016
(2016/4/1-2017/3/31)
Net cash provided by operating activities 3,732 10,195
Net cash used in investing activities 19,032 22,206
Net cash provided by (used in) financing activities 27,970 92
Effect of exchange rate changes on cash and cash equivalents 648 689
Net increase in cash and cash equivalents 13,318 11,414
Cash and cash equivalents at beginning of the year 5,208 18,526
Cash and cash equivalents at end of the year 18,526 7,112

Home > Investor Relations > IR Library > Statements of Cash Flows (consolidated)
© Copyright TOWA PHARMACEUTICAL CO.,LTD. All Rights Reserved.